⚡️What a terrific FRS with inspiring talks, exciting science, excellent audience engagement! Congratulations & big thanks to our wonderful presenters Ismael Calandri Keir Yong Betty Tijms Sara Rose Dunlop PhD, fantastic chairs Baayla DC Boon, Dr. Kandiah & the Atypical Alzheimer's Disease PIA community 🎉👏

I am deeply grateful for the opportunity to be part of this scientific presentation. Thank you to everyone involved for such a remarkable experience! Special thanks to the audience for their questions and ideas.

#AAIC24 #AAIC2024 Dr. Nilton Custodio from Peru 🇵🇪 sharing the work in recruiting for LatamFingers. Amazing work 👏👏👏👏 LatAm -FINGERS Nilton Custodio

Strategies and action points to boost dementia research in LMICs while avoiding scientific 'neocolonialism.' Fantastic plenary by Ricardo F. Allegri ! Fleni Alzheimer's Association

Please re-Tweet this terrific resource on #LGBTQ+ and #dementia (image: @3uknz) #Alzheimers

Annual World-Wide FINGERS meeting at #AAIC24. More than 60 countries represented, being 12 from Latin America. LatAm FINGERS is proud to be part of this powerful network Lucía Crivelli Ricardo F. Allegri Paulo Caramelli sonia brucki Ismael Calandri Nilton Custodio

🚨 Exciting News! 🚨 ANPHY-SLeep: An open sleep database from healthy adults using high-density scalp EEG is now published in Scientific Data Nature Portfolio ! 🧠💤 #OpenScience #SleepResearch #EEG Access the data here: 👉 doi.org/10.17605/osf.i… 👉nature.com/articles/s4159…

Peripheral inflammation markers predict survival in FTD—sounds promising! Targeting inflammation could open up new avenues for prevention and treatment.

It is inspiring to hear the voice of the participants in an article. We need to include in our studies a way to bring the knowledge created to the participants and at the same time make them actors of that process.

MHRA approved the use of Lecanemab in Alzheimer's Disease!🤯 Alzheimer's wonder-drug lecanemab gets go ahead for use in Britain telegraph.co.uk/news/2024/08/2…

The BeyeOMARKER study design paper is out! In BeyeOMARKER we will screen 700 individuals with plasma p-tau217 at an eye clinic, and further characterize 150 of them with Amyloid & Tau PET, MRI, retinal imaging and cognitive & cortical vision assessment. Thanks to the great team

🚨 Paper Alert! 🚨🧠 We explored resting-state networks in individuals with post-COVID cognitive symptoms in Argentina and found a significant reduction in brain network efficiency. doi.org/10.1002/neo2.7…

Wow, GLP-1 is changing the history of chronic diseases.

Sometimes the rarity of a disease keeps us away from creating clinical trials, however it should not be so. One solution, the N-of-1 Trials, a good thread with the most relevant literature.

I've been extensively using Vincent Arel-Bundock {modelsummary} R package for both teaching and research and it is a delight. But I'm here to recommend this presentation of {marginaleffects}, a beautiful approach to interpreting model estimates: youtube.com/watch?v=ANDC_k…

[PAQUETE 📦] - Si sos fan de armar presentaciones en R con {xaringan}, tenes que pasar a visitar al paquete {renderthis}, con quien vas a poder exportar tu trabajo a pdf, html, pptx y más! 🌐 jhelvy.github.io/renderthis/ ✍🏼 John Paul Helveston | garrick aden-buie #RStats #RStatsES #Rtips

Check the research briefing of our recent paper in Nature Aging that described the association between the planetary health diet and cognitive decline in #ELSABrasil. Kudos to the brilliant Natalia Goncalves! nature.com/articles/s4358….

In this study, the authors investigated whether neuropathologic processes contribute to brain regional topologic properties of integration and segregation and brain network resilience in #ParkinsonDisease: bit.ly/3WuQBD1 #NeuroTwitter

With deep sorrow, we bid farewell to Dr. Lopera, a visionary researcher and cherished friend. As a founder of our consortium, his pioneering work in Alzheimer's research, has left an indelible mark. His passion, and brilliance will forever inspire us. Rest in peace, Francisco.

Follow the link to support!